Molecular epidemiology of hepatitis A virus in Amsterdam, the Netherlands

Author(s):  
S.M. Bruisten ◽  
J.E. van Steenbergen ◽  
A.S. Pijl ◽  
H.G.M. Niesters ◽  
G.J.J. van Doornum ◽  
...  
2001 ◽  
Vol 16 (5) ◽  
pp. 519-524 ◽  
Author(s):  
Kwan Soo Byun ◽  
Jong Hun Kim ◽  
Ki-Joon Song ◽  
Luck Ju Baek ◽  
Jin-Won Song ◽  
...  

2017 ◽  
Vol 61 (04) ◽  
pp. 463-472 ◽  
Author(s):  
R. ZHANG ◽  
L. XIA ◽  
J. CHEN ◽  
Y. GONG ◽  
L. ZHANG ◽  
...  

2017 ◽  
Vol 65 (1) ◽  
pp. 10-15 ◽  
Author(s):  
X. Wen ◽  
D. Zhu ◽  
A. Cheng ◽  
M. Wang ◽  
S. Chen ◽  
...  

2011 ◽  
Vol 139 (8) ◽  
pp. 1172-1180 ◽  
Author(s):  
L. VERHOEF ◽  
H. J. BOOT ◽  
M. KOOPMANS ◽  
L. MOLLEMA ◽  
F. VAN DER KLIS ◽  
...  

SUMMARYThe prevalence of antibodies to hepatitis A virus (HAV) was assessed in a nationwide sample (n=6229) in The Netherlands in 2006–2007, and compared to the seroprevalence in a similar study in 1995–1996 (n=7376). The overall seroprevalence increased from 34% in 1995–1996 to 39% in 2006–2007, mainly due to vaccination of travellers and an increased immigrant population. Risk factors remain travelling to, and originating from, endemic regions, and vaccination is targeted currently at these risk groups. Our results show a trend of increasing age of the susceptible population. These people would also benefit from HAV vaccination because they are likely to develop clinically serious symptoms after infection, and are increasingly at risk of exposure through imported viruses through foods or travellers. The cost-effectiveness of adding elderly people born after the Second World War as a target group for prophylactic vaccination to reduce morbidity and mortality after HAV infection should be assessed.


2003 ◽  
Vol 84 (12) ◽  
pp. 3191-3201 ◽  
Author(s):  
Mauro Costa-Mattioli ◽  
Anna Di Napoli ◽  
Virginie Ferré ◽  
Sylviane Billaudel ◽  
Raul Perez-Bercoff ◽  
...  

Knowledge of the molecular biology of hepatitis A virus (HAV) has increased exponentially since its identification. HAV exploits all known mechanisms of genetic variation to ensure survival, including mutation and genetic recombination. HAV has been characterized by the emergence of different genotypes, three human antigenic variants and only one major serotype. This paper reviews the genetic variability and molecular epidemiology of HAV. Its evolutionary mechanisms are described with particular emphasis on genetic recombination and HAV mutation rate. Genotypic classification methods are also discussed.


2021 ◽  
Vol 27 (6) ◽  
pp. 1742-1745
Author(s):  
Sumathi Ramachandran ◽  
Guo-Liang Xia ◽  
Zoya Dimitrova ◽  
Yulin Lin ◽  
Martha Montgomery ◽  
...  

2012 ◽  
Vol 17 (6) ◽  
Author(s):  
C Carvalho ◽  
H L Thomas ◽  
K Balogun ◽  
R Tedder ◽  
R Pebody ◽  
...  

In October 2011, two primary cases of hepatitis A virus (HAV) infection with identical HAV genotype IB strains to those seen in other outbreaks associated with semi-dried tomatoes were reported in England. Both cases had consumed semi-dried tomatoes. Epidemiological investigations revealed two additional cases of genotype IB strains with different sequences who also reported having consumed semi-dried tomatoes. In November, five cases of HAV infection with closely related strains were identified in the Netherlands. A foodborne multiple-strain outbreak is suspected.


2015 ◽  
Vol 87 (7) ◽  
pp. 1218-1224 ◽  
Author(s):  
Moumita Bose ◽  
Sujoy Bose ◽  
Anjan Saikia ◽  
Subhash Medhi ◽  
Manab Deka

Sign in / Sign up

Export Citation Format

Share Document